According to the report North America Aptamers Industry, published by Market Data Forecast, The Industry was worth $ 48.03 Million in 2016 and estimated to reach $ 103.07 Million by the end of 2021 with a growing potential of 16.50 %.
Aptamers are oligonucleotides that bind to target protein, lipid, or nucleic acid molecules with a high specificity. The enormous opportunities offered by the Industry for the key players are the drug discovery, biomarker discovery, and diagnostics segments.
The launch of Macugen, the first aptamer drug and the first diagnostic test for testing mycotoxins in grains has recognised the potential of aptamers in diagnostics and therapeutics. So, the Industry for aptamers is expected to grow, backed by technological advancements with respect to selection processes and synthesis.
Browse Industry data tables and in-depth TOC of the North America Aptamers Industry to 2021 @ www.marketdataforecast.com/market-…mers-market-1135/
The North America Industry is driven by advancement in technology, availability of R&D investments in pharmaceutical and biotechnology industries, low cost and high efficacy in binding to large molecules compared to antibodies. Ethical issues for some aptamers, Stringent regulations in use of aptamers, slow in reaching the Industry place due to regulatory hurdles may hinder the growth of the Industry.
Free sample of the report is available @ www.marketdataforecast.com/market-…35/request-sample
The North America Aptamers Industry is broadly categorized by type into Peptide aptamers, Nucleic Acid aptamers. Nucleic Acid aptamers are further categorized into DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers.
Based on Application the Industry is categorized into Therapeutics Development, Diagnostics, Research and Development and on the basis of end users the Industry is segmented into Pharmaceutical Companies, Bio-Pharmaceutical companies, Academic and Research Centres and on the basis of geography, the North America Aptamers Industry is analysed under various regions namely U.S, Canada.
Inquire report @ www.marketdataforecast.com/market-…rket-1135/inquire
Some of the major companies influencing the North America Aptamers market are AM Biotechnologies, Aptagen, Aptamer Sciences Inc., Aptamer Solutions Ltd., Aptus Biotech S.L., Base Pair Biotechnologies Inc., NeoVentures Biotechnology Inc., SomaLogic Inc, TriLink BioTechnologies Inc., and Vivonics, Inc.
Key Points from Table of Contents
- Executive Summary
- Key Inferences
- New Developments
Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
North America Aptamers Industry: Segmentation
- By Type
- o Peptide Aptamers
- o Nucleic Acid Aptamers
- By Application
- o Therapeutics Development
- o Diagnostics
- o Research and Developments
- By End Users
- o Pharmaceutical Companies
- o Bio-Pharmaceutical Companies
- o Academic and Research Centers
- United States
- PESTLE analysis
- Porter’s Five analysis
Industry Leaders' Analysis
Avail report @ www.marketdataforecast.com/market-…/request-discount
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information:Make an Inquiry about this report HERE!